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Abstract 
 
Purpose: Converting the measurable quantities to patient organ doses in projection radiography is usually 
based on a standard-sized patient model and a specific radiation quality, which are likely to differ from 
the real situation. Large inaccuracies can therefore be obtained in organ doses, because organ doses are 
dependent on the exposure parameters, exposure geometry and patient anatomy. In this study, the effect 
of radiation quality and patient thickness on the organ dose conversion factors were determined. 
Methods: In this study, the posterior–anterior projection radiograph of the thorax was selected in order to 
determine the effect of radiation quality (tube voltages of 70 kV to 130 kV and total filtrations of 3 mmAl 
to 4 mmAl + 0.2 mmCu) and patient thickness (anterior–posterior thicknesses of 19.4 to 30.8 cm) on the 
breast and lung dose conversion factors. For this purpose, Monte Carlo simulation programs ImpactMC 
and PCXMC were used with computed tomography examination data of adult male and female patients 
and mathematical hermaphrodite phantoms, respectively.  
Results: Compared to the reference beam quality and patient thickness, the relative variation range in 
organ dose conversion factors was up to 74% for different radiation qualities and 122% for different 
patient thicknesses. 
Conclusions: Conversion factors should only be used with comprehensive understanding of the exposure 
conditions, considering the exposure parameters, exposure geometry and patient anatomy they are valid 
for. This study demonstrates that patient thickness-specific and radiation quality-specific conversion 
factors are needed in projection radiography. 
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Introduction 
According to current knowledge, the risk of radiation-induced cancer is assumed to be linearly dependent 
on the cumulated radiation dose [1]. The International Commission on Radiological Protection (ICRP) 
does not recommend the effective dose to be used for individual risk assessment [1]. The absorbed organ 
dose is a better measure for estimating the patient risk than the effective dose [1–3]. Estimating the 
radiation-induced risk of cancer to the patient from an X-ray examination requires knowledge of organ 
doses, not just the dosimetric quantities used for dose monitoring. Accurate estimation of the radiation 
dose to the patient can be based on conversion factors from measured dose data to patient organ doses by 
using information about the exposure parameters, exposure geometry and patient anatomy. The patient 
models used for calculating conversion factors are typically standard-sized and do not consider 
differences in patient anatomy.  
 
A report by the American Association of Physicists in Medicine (AAPM) provides guidance for patient 
size corrections in computed tomography (CT) imaging [4], and can therefore be used in estimating 
patient size-specific doses from measured dose data (in terms of CT air kerma index, CK). CK is already 
closer to organ doses than the measurable quantities in projection imaging because it is measured in a 
phantom, and the internal phantom and patient dose distributions are more uniform in CT than in 
projection imaging. In projection imaging, the dose to an organ is high on the entrance side of the X-ray 
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beam and low on the exit side. Therefore, much larger variations in organ doses can be expected in 
projection imaging than in CT. The dose levels in interventional radiology are many orders of magnitude 
higher than in conventional projection imaging, and sometimes even higher than in CT. However, there 
are currently no generally used correction factors for patient size in conventional projection imaging and 
interventional radiology. The best accuracy in patient dose estimation can be achieved when individual 
and examination-specific simulation is performed based on CT data of the patient. This method is 
commonly used in radiation therapy treatment planning. However, this method is very time-consuming 
and, due to the lack of appropriate CT data, not practical on a routine basis for dose estimation in X-ray 
imaging. 
 
Different levels of accuracy are needed for organ dose estimations depending on the purpose of use. Some 
publications include tabulated organ and effective doses for certain diagnostic procedures and 
examinations [5,6]. Typical dose values are usually accurate enough as estimates for the order of 
magnitude of the exposure and subsequent cancer risk. However, the use of such values is not sufficient 
for accurate dose calculations for individual patients due to the individual patient and examination 
conditions. If a tabulated value alone is used for patient dose estimation, the unknown incident dose level 
adds additional uncertainty to the estimation and may have a major effect on individual doses. Therefore, 
more accurate dose conversion factors from measured values to organ doses are needed for research and 
the optimization of patient doses. Conversion factors are typically given for a specific examination type 
and for a single or a few radiation qualities with certain assumptions about the beam size, its positioning, 
and the patient size [5–9] and determined by anthropomorphic phantom measurements or Monte Carlo 
simulations. However, differences in patient size are rarely taken into account. There are various software 
programs designed to calculate organ doses in diagnostic X-ray examinations, for example XDOSE [10], 
CALDose_X [11], PCXMC [12] and ImpactMC [13,14]. According to the results of a Coordinated 
Research Project (CRP E2.10.08) of the International Atomic Energy Agency [15], the most common 
methods for effective and organ dose estimation in projection imaging were PCXMC [12] and NRPB-
R262 and NRPB-SR262 [6,16]. 
 
Posterior–anterior (PA) examination of the thorax is one of the most common radiographic examinations 
in projection X-ray imaging [17–19]. In thorax PA examination, special attention should be paid to the 
two most radio-sensitive chest organs, the breasts and the lungs, which are located almost entirely within 
the primary radiation beam. The tissue weighting factor for the breast has been increased from 0.05 to 
0.12 when comparing ICRP Publications 60 and 103 [1,20], and has reached the value of the lung. This 
increase is due to the evidence on the radiosensitivity of the breast and because more emphasis has been 
put on cancer incidence rather than cancer mortality by the ICRP. 
 
The aim of this study was to determine the effect of patient thickness on the dose conversion factors by 
Monte Carlo simulations of a thorax PA examination, based on CT examination data of adult male and 
female patients with different anterior–posterior thicknesses and thickness-adjusted mathematical 
hermaphrodite phantoms. Moreover, the effect of different radiation qualities based on a standard-sized 
mathematical hermaphrodite phantom was determined. 
Materials and methods 
Risk estimates are normally based on organ doses or the effective dose, which cannot be directly 
measured. Therefore, measurable quantities based on air kerma are generally used for clinical dosimetry. 
In the energy range used in X-ray diagnostics, air kerma equals the dose absorbed to air, and air kerma is 
therefore the quantity used throughout this paper, as it is internationally recommended [21,22]. 
ImpactMC (version 1.4.0.0, 2014) from CT Imaging, Erlangen, Germany [13,14], allows the user to 
generate 3D dose distributions with user-defined acquisition parameters from retrospective volume CT 
data. ImpactMC was designed to simulate CT devices but it can also be used to simulate projection 
radiography, as stated in the latest manual [23]. There are no validation papers for projection radiography 
so far, but the localizer mode can be used in ImpactMC with adapted geometry and spectra (Paul Deak, 
November 1, 2016, personal communication) [24,25]. In this study, ImpactMC was used to determine the 
effect of patient thickness on conversion factors. Anonymised CT patient data from 5 male and 5 female 
adult patients investigated in 2011 at the Inselspital University Hospital, Bern, Switzerland, were used in 
ImpactMC simulations. The patient selection criteria were that a) the patients had undergone trauma CT, 
b) the scanned region covered the lungs and c) both genders were represented equally by 5 five different 
patient sizes, ranging from extra small (XS) to small (S), medium (M), large (L), and extra large (XL) 
(see Table 1). The patient thickness measured at the mid-sagittal plane at the mamilla level in the 
anterior–posterior (AP) dimension (see Figure 1) was used to define the patient size. The patients used in 
ImpactMC simulations had been scanned in a supine position with the trauma CT protocol at a slice 
thickness of 1.5 mm, and the Siemens convolution kernel was B20f. The reference X-ray spectrum (X-ray 
tube voltage, anode angle, filtration, see Table 2) used in ImpactMC simulations was generated using 
Spektripaja 3.0 program [26]. The Be window used in Spektripaja was 0.8 mm, and the air layer thickness 
was 1 m. 
Table 1. Patient thickness was measured at the patient’s mid-sagittal plane at the mamilla level in the 
anterior–posterior (AP) dimension. 
 
Patient size1 AP thickness (cm) 
MXS 19.4 
MS 22.4 
MM 24.7 
ML 28.1 
MXL 30.8 
FXS 20.8 
FS 22.2 
FM 23.6 
FL 25.9 
FXL 26.9 
1 Male (M), Female (F), Extra small (XS), Small (S), Medium (M), Large (L), Extra large (XL) 
 
Figure 1. The arrow indicates the patient thickness measured at the mid-sagittal plane at the mamilla 
level in anterior-posterior (AP) dimension. 
Prior to the ImpactMC simulations, the patient table was removed from the DICOM images by 
thresholding and masking in the computer programs 3DSlicer (version 4.4) and Matlab (version R2014b). 
The position of the X-ray detector was estimated to be at the sternum position in order to fix the position 
similarly for male and female patients. The X-ray beam size was adjusted to 900 cm2 (30 cm × 30 cm) so 
that it covered the lungs of all patients at the same focus to detector distance (FDD) of 200 cm (see Figure 
2). The default density and material definition files in ImpactMC were used. An air kerma output (input 
parameter in ImpactMC) of 1 mGy was assumed at the FDD and the incident air kerma at the focus to 
skin distance (FSD) was then calculated based on the patient thickness. Organ dose conversion factors 
were calculated relative to the incident air kerma. If conversion factors for the air kerma–area product are 
needed, these values are divided by the field size at the patient entrance surface. If conversion factors 
from the entrance surface air kerma are needed, these values are divided by the backscatter factor, which 
is close to 1.4 [27] in this case. 
The PCXMC 2.0 [12] includes mathematical hermaphrodite phantoms of ages 0, 1, 5, 10, 15 and adult. In 
this study, PCXMC was used to determine the effect of radiation quality and patient thickness on 
conversion factors. The standard dimensions for an adult phantom in PCXMC (height, mass and trunk 
thickness) are given in the Reference column in Table 2. The X-ray spectra (see Table 2) used in PCXMC 
simulations was generated in PCXMC. An incident air kerma (input parameter in PCXMC) of 1 mGy was 
used for the simulations and organ dose conversion factors were calculated relative to the incident air 
kerma. 
Table 2. X-ray beam, patient and exposure parameters for thorax posterior-anterior (PA) examination in 
PXCMC simulations. 
Parameter Reference Variations 
Tube voltage (kV) 120 70, 80, 90, 100, 110, 1302 
Filtration (mmAl/mmCu) 4.0/0.2 3.0/0.0, 5.0/0.0, 4.0/0.12 
X-ray system anode W-anode, target angle 20°  
Half-value layer (mmAl) 8.1 2.6–8.52 
Focus to image distance (cm) 200  
Focus to skin distance (cm) 177 166.2–177.63 
Image width (cm) 352 483 
Image height (cm) 40  
X-ray beam width (cm) 31.0 39.9–42.63 
X-raybeam height (cm) 35.4 33.2–35.53 
Zref1 55  
Phantom exit-image distance 3.0  
Phantom height (cm) 178.6  
Phantom mass (kg) 73.2 68.6–174.13 
Phantom trunk thickness (cm) 20.0 19.4–30.83 
1Zref is the z coordinate of an arbitrary point inside the phantom, through which the central axis of the x-ray beam is directed. 
2Radiation quality: image width is adjusted for the PCXMC phantom with standard dimensions. Variations for tube voltage, 
filtration and HVL were applied. 
3Patient thickness: image width for all patients is adjusted based on the largest thickness-adjusted PCXMC phantom. 
Variations for FSD, X-ray beam width and height, phantom mass and phantom trunk thickness were applied. 
 
Figure 2. Examples of beam eye views in thorax PA projection in PCXMC simulations (left) and in 
ImpactMC simulations (right). In the left image, different colours represent organs and the white areas are 
bones. In the right image, yellow/lightest is the highest dose and blue/darkest is the lowest. 
 
Simulations for different patient sizes were performed in PCXMC by using the phantom masses that 
result in the measured male patient thicknesses (anterior–posterior thicknesses of 19.4 to 30.8 cm). 
Phantom masses were calculated based on the standard height of the PCXMC phantom (see Table 2) and 
the measured patient thicknesses (see Table 1). The image width was adjusted so that the X-ray beam 
covered the lungs of the largest patient (MXL), and this image width was used for all other male patient 
sizes (see Tables 1 and 2). PCXMC scales the patient model and the X-ray beam dimensions based on the 
given height and mass of the phantom. The effect of radiation quality on the conversion factors was 
determined in PCXMC with standard dimensions with four different filtration combinations together with 
a range of tube voltages (Table 2). Conversion factors were presented as a function of the tube voltage 
and the half-value layer (HVL). 
 
Lungs and breasts were segmented from the patient CT images by using 3DSlicer (version 4.4) and 
Matlab (version R2014b), and organ doses were determined from these volumes of interest (VOIs). 
Breasts were segmented only for the female patients (anterior–posterior thicknesses of 20.8 to 26.9 cm). 
In PCXMC, the absorbed doses to lungs and breasts were determined as organ doses in the hermaphrodite 
phantom. Dose conversion factors were calculated by dividing the organ doses from ImpactMC and 
PCXMC simulations by the incident air kerma and expressed in µGy/100 µGy. This unit was selected in 
order to represent the conversion factors as percentages, when the incident air kerma is 100 µGy. The 
value of 100 µGy is close to the incident air kerma calculated based on the Finnish DRL as the entrance 
surface air kerma for thorax PA examination (0.12 mGy) [28] and the backscatter factor of 1.4 [27].The 
reference conversion factors were calculated for the PCXMC phantom with standard dimensions. The 
variation ranges in the conversion factors were found at the minimum and maximum values of the half-
value layer (HVL) and the anterior–posterior (AP) thickness. The relative variation ranges of the 
conversion factors were calculated as the difference between the maximum and minimum values relative 
to the mean value and the reference value. 
Results 
Radiation quality 
In Figures 3a-b and 4a-b, conversion factors from incident air kerma to lung and breast doses, 
respectively, for the thorax PA examination simulated in PCXMC with different radiation qualities are 
presented as a function of the tube voltage and HVL. The tube voltage is not a good parameter for 
specifying the radiation quality alone; the total filtration also has to be defined. As a function of HVL, the 
conversion factors are more convergent than as a function of the tube voltage. 
 
 
Figure 3a. Conversion factors from the incident air kerma to the lung dose for thorax PA examination 
calculated with PCXMC for different total filtrations as a function of the tube voltage. 
 
 
Figure 3b. Conversion factors from the incident air kerma to the lung dose for thorax PA examination 
calculated with PCXMC for different total filtrations as a function of the HVL. 
 
 
Figure 4a. Conversion factors from the incident air kerma to the breast dose for thorax PA examination 
calculated with PCXMC for different total filtrations as a function of the tube voltage. 
 
 
Figure 4b. Conversion factors from the incident air kerma to the breast dose for thorax PA examination 
calculated with PCXMC for different total filtrations as a function of the HVL. 
 
Patient thickness 
In Figure 5, the organ dose conversion factors from ImpactMC simulations for patients with different 
anterior–posterior thicknesses (Table 1) are compared with the values calculated using the thickness-
adjusted mathematical phantoms in PCXMC.  
 
 
 
Figure 5. Organ dose conversion factors and the related uncertainties for lungs and breasts calculated 
using simulations with ImpactMC for patient data and with PCXMC for thickness-adjusted phantom data 
for different patient AP thickness at the reference radiation quality (120 kV and 4 mmAl + 0.2 mmCu). 
 
When the X-rays penetrate through the body, the effect of patient thickness can be seen, as the dose inside 
the patient decreases as a function of the patient thickness (Figure 5). Linear regression lines were fitted 
to the ImpactMC results for lungs and breasts, and the corresponding squared linear correlation 
coefficients (R2) are 0.93 and 0.97, respectively. The ImpactMC and PCXMC results for lungs have the 
same inclination, the ImpactMC results being up to 16% lower than the PCXMC results at the same 
patient thickness. The ImpactMC results for breasts show a different inclination than the PCXMC results, 
and for small patients, the ImpactMC results are up to 52% higher than the PCXMC results, and for large 
patients, the ImpactMC results are up to 55% lower than the PCXMC results of patients at the same 
patient thickness: 208 mm (female XS) for small patients and 269 mm (female XL) for large patients, 
respectively. 
 
Table 3 presents the conversion factors according to Figure 5 and the difference between the maximum 
and minimum doses relative to the mean dose and the reference dose. Reference values are calculated for 
the PCXMC phantom with standard dimensions (Table 2). Table 3 represents the variations that may be 
encountered in lung and breast doses, even though the measurable incident dose level is the same. The 
highest variations relative to the mean and reference values were found in ImpactMC results for breasts. 
According to the PCXMC results, the organ doses differ by a factor of up to 3.5 depending on the tube 
voltage and filtration or HVL and filtration combinations. Patient thickness has an effect of slightly larger 
order of magnitude; for a small-sized adult, organ doses are up to 5.7 times larger than for a large adult. 
Compared to the reference values, the relative variation range in organ dose conversion factors is up to 
74% for different radiation qualities and 122% for different patient thicknesses. 
 
Table 3. Relative variation ranges in conversion factors from measured dose data to patient breast and 
lung doses. The conversion factors at the minimum and maximum values of the half-value layer (HVL) 
and the anterior–posterior (AP) thickness are presented. 
Radiation quality 
  Minimum 
HVL: 
2.6 mmAl  
Maximum 
HVL: 
8.5 mmAl  
Mean 
 
Reference1 
HVL: 
8.1 mm Al 
Variation relative to 
 reference 
  Conversion factors (µGy/100µGy) variation range (%) 
PCXMC Lung 45 98 75 96  55 
Breast 8 28 19 27  74 
Patient thickness 
  Minimum  
AP thickness: 
194 mm  
Maximum 
AP thickness: 
308 mm  
Mean Reference1 
AP thickness: 
200 mm 
Variation relative to 
 reference 
  Conversion factors (µGy/100µGy) variation range (%) 
PCXMC Lung 102 63 83 96  40 
Breast 30 10 19 27  73 
ImpactMC Lung 86 56 74 96  31 
Breast 402 72 22 27  122 
1 PCXMC phantom with standard dimensions 
2 The minimum and maximum AP thicknesses for ImpactMC breast results are 208 mm and 269 mm, respectively (female 
extra small and extra large patients) 
 
Uncertainty calculation 
In Monte Carlo simulations, uncertainties include statistical uncertainties and uncertainties related to the 
repeatability of the dose determination, but the major source of uncertainties are the uncertainties related 
to the attenuation coefficients and inadequacies in the description of the X-ray source and the patient. The 
number of simulated interactions in the organ considered defines the level statistical uncertainties [12].  
In ImpactMC, 109 photons were used, and the statistical uncertainty was estimated to be 2.0% (k = 2). 
The calculated uncertainty based on the minimum and maximum values of the mean doses for the lung 
and breast VOIs in repeated dose determinations was up to 3.0% (k = 2). Therefore the total uncertainty 
of dose values was 3.6% (k = 2) for the VOIs. In patients, the shapes, volumes and locations of the organs 
are patient-specific and vary considerably. 
In PCXMC, the statistical uncertainties in organ dose values were up to 1.2% (k = 2) for breasts and up to 
0.4% (k = 2) for lungs at 106 photons. The shapes, volumes and locations of the organs in the PCXMC 
phantom are well defined, but the phantom does not represent a realistic patient. The dominating sources 
of uncertainties of organ doses in PCXMC are the differences between the phantom and a realistic patient, 
and the differences between the simulated and true irradiation geometry.  
Discussion 
The international recommendation for the uncertainty of dose measurements in diagnostic radiology is 
7% (k = 2) if the value is used for the optimization of patient doses [21,22,29]. Even a 10% reduction in 
the patient dose is a worthwhile objective for optimization [22]. If optimization tasks are close to the 10% 
level, this sets high requirements for accuracy in patient dose estimations. This emphasizes the need for 
correct conversion factors from measurable doses to patient organ doses. The next step, risk estimation, 
may have large uncertainties of up to an order of magnitude or more [30]. However, an uncertainty of  
20% is acceptable in cases where the organ dose is low and for radiation survey measurements [22], but 
an uncertainty of 30-50 % can be accepted when organ doses are low [21]. In the present study, 
uncertainties are associated to the different simulation programs used (ImpactMC and PCXMC) and the 
dose determination methods. However, large variations in the organ dose conversion factors are related to 
the choice of a standard-sized patient instead of a specific-sized patient. Moreover, the choice of the 
radiation quality has a large effect on the organ dose conversion factors. 
 
The highest variation in organ dose conversion factors relative to the reference value, 122%, were found 
in ImpactMC results for breasts, which is likely to be due to the differences between the size and position 
of the breasts of the hermaphrodite PCXMC phantom and the female patients. For FS, FM, FL and FXL 
patients, the breasts were not completely within the primary beam, which is often the clinical situation 
due to proper lateral and inferior collimation. Therefore, the larger variation ranges in the ImpactMC 
breast results compared to the PCXMC breast results are due to larger variations in the patient anatomy 
than in the phantom construction. Moreover, the reference values were calculated for the PCXMC 
phantom with standard dimensions, which corresponds to a patient size between XS and S (see Tables 1 
and 2). For comparison, in the energy range between 60 and 200 keV, the range of variation in breast 
doses between different voxel models have been found to be up to 84% in the PA projection of whole 
body irradiations [31]. 
 
Both the ImpactMC and PCXMC lung and breast dose conversion factors of the present study showed 
good linear correlation with the patient AP thickness. The ImpactMC and PCXMC lung results were 
parallel, but the ImpactMC breast results crossed the PCXMC breast results approximately at the AP 
thickness of the MM sized patient. These differences might be due to the fact that the thickness 
adjustment is more realistic for modifying the lung size than the breast size. For medium sized patients, 
the conversion factors for breasts seem to be similar for patients and mathematical phantoms, at least 
according to the small patient cohort of the present study. However, as can be seen from the conversion 
factors for lungs, the thickness-adjusted mathematical phantoms seem to overestimate the lung doses of 
patients. 
 
In CT examinations of the thorax, dose underestimations of 8%–15% on average depending on patient 
size with highest underestimation values of 37% have been found in Monte Carlo simulations based only 
on CT data [32]. In projection radiography, however, the internal phantom and patient dose distributions 
are not as uniform as in CT. It has previously been shown that when patient size is neglected in the choice 
of the lung dose conversion factor, relative errors of up to 34% for the PA projection in interventional 
fluoroscopy procedures can be encountered [33]. Furthermore, the organ dose to an underweight patient 
will be underestimated and the organ dose to an overweight patient overestimated if patient size is 
neglected when choosing a dose conversion factor [33]. The variation in conversion factors from entrance 
surface air kerma to the effective dose between different-sized male and female phantoms has been 
reported to vary in the range of 1.5–2 in projection radiography [34]. The variation ranges for organ doses 
can be even higher due, for example, to different X-ray beam positioning [15]. The deviation in lung dose 
between patients of 100 kg in mass and 1.7 m in height and an average adult has been reported to be 27% 
in thorax PA examinations, and that the body weight or height alone is a poor parameter for lung dose 
estimation [35]. It has also been found that a better parameter, the body mass index (BMI), should be used 
instead, and that the BMI is approximately linearly proportional to the patient trunk thickness [35]. 
Furthermore, in the energy range between 60 and 200 keV, the range of variation in lung doses between 
different voxel models have been found to be up to 31% in the PA projection of whole body irradiations 
[31]. The results of the present study are in line with these previous studies, and further emphasize that 
the patient thickness has a larger relative effect on the breast dose than on the lung dose due to the 
position of the breasts at the patient exit in the thorax PA examinations and to the position of the lungs 
entirely within the primary beam.  
 
The PCXMC results of the present study for different radiation qualities were in a good agreement with 
published or calculated lung and breast dose conversion factors from the air kerma–area product to organ 
doses [7,9,36,37]. In thorax PA examination, the organ dose in relation to incident air kerma values 
increased as a function of increasing tube voltage, HVL and total filtration. Filtration of the X-ray 
spectrum is used to eliminate the low energy photons that would otherwise be absorbed by the patient and 
thus increase the radiation dose. This dose reduction effect is seen at the patient entrance. In the PA 
projection, breast and lung dose conversion factors increase as a function of total filtration, because the 
spectrum has lost the low energy photons and the beam energy has increased when patient’s tissues have 
further filtered medium energy photons. This aspect should be taken into account when entrance surface 
air kerma values for patients are compared with each other or with the diagnostic reference level. For 
patients exposed with different filtration, the entrance surface air kerma can be the same, but the absorbed 
dose in organs can still differ considerably. It has been shown that for low photon energies, the 
differences in organ doses between different voxel models may amount to hundreds of per cent [31]. 
 
The simulation programs include certain study limitations. In PCXMC, the patient model is based on a 
standard MIRD-type phantom that does not correspond to a realistic patient. In PCXMC, it is possible to 
scale the phantom size by changing the phantom height and mass. When the actual height and mass of the 
patient are used to scale the phantom, the resulting phantom thickness does not correspond to the patient 
thickness [15]. Therefore, the phantom mass has to be adjusted so that resulting the phantom thickness 
equals the patient thickness. The scaled phantoms used in PCXMC do not represent the anatomical 
changes of different-sized patients, since in PCXMC the sizes of all organs and tissues are simply 
increased or decreased according to horizontal and vertical scaling factors. For example, no extra inter-
organ fat is inserted. Anatomically, the lung size is not necessarily larger for large patients, but the scaling 
of the PCXMC phantom also increases the lung size.  
 
Other methodological limitations of this study are related to the patient data available and the image 
characteristics. The patients were trauma patients and the position of anatomical structures did not 
represent that of healthy individuals. Moreover, in the supine position, as used for CT, breast tissue has a 
more lateral location than in the upright position used for thorax PA radiography. Furthermore, 
inspiration is less pronounced in the supine position, and other organs are also in different positions in 
upright and supine positions, which may affect the results. Lungs and breasts were segmented from the 
patient CT images, which causes variation due to the segmentation method and patient anatomy. The X-
ray beam size was the same for all patients simulated in ImpactMC, even though in clinical radiography, 
the field is always adapted to the individual patient. However, the lungs were fully covered by the X-ray 
beam, so that the uncertainty related to the use of a standard-sized beam was considered minor. The 
position of the X-ray detector was estimated to be at the sternum position in order to fix the position 
similarly for male and female patients, which may cause differences within the patient FDDs. 
 
Conclusions 
The present study aimed to determine the effect of patient thickness on the dose conversion factors by 
Monte Carlo simulations of a thorax PA examination, based on CT examination data of adult male and 
female patients with different anterior–posterior thicknesses and thickness-adjusted mathematical 
hermaphrodite phantoms, and the effect of different radiation qualities based on a standard-sized 
mathematical hermaphrodite phantom. Converting the measurable quantities to patient organ doses is 
usually based on a standard-sized patient model and a specific radiation quality, which are likely to differ 
from the real situation. Conversion factors should only be used with comprehensive understanding of the 
exposure conditions, considering the exposure parameters, exposure geometry and patient anatomy they 
are valid for. When conversion factors are used for other exposure conditions, the possible large 
variations in organ doses should be understood. This study demonstrates that patient thickness-specific 
and radiation quality-specific conversion factors are needed in projection radiography. 
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